Mahsa Afsari Kashani

1 ta ish

Tabriz University of Medical Sciences

1. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

   Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

   MaqolaOAOchiq kirish20235 iqtibos

   ABIABI:AkademIndex/2026.other.130704